JGAVX | RMEBX | JGAVX / RMEBX | |
Total Expense Ratio | 0.94 | 1.07 | 88% |
Annual Report Gross Expense Ratio | 1.01 | 1.07 | 94% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 6.681 | 9.495 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.5B | 109B | 6% |
Annual Yield % from dividends | 1.07 | 1.12 | 96% |
Returns for 1 year | 11.84 | 11.31 | 105% |
Returns for 3 years | 39.89 | 28.70 | 139% |
Returns for 5 years | 89.83 | 60.65 | 148% |
Returns for 10 years | N/A | 77.57 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AAAGX | 19.24 | 0.20 | +1.05% |
Thrivent Large Cap Growth A | |||
AMPCX | 34.92 | 0.36 | +1.04% |
American Funds AMCAP C | |||
BAFYX | 10.57 | 0.08 | +0.76% |
Brown Advisory Sustainable Sml-Cp Cr Ins | |||
NTKLX | 73.09 | 0.17 | +0.23% |
Voya Multi-Manager International Sm Cp A | |||
FPHAX | 24.75 | -0.12 | -0.48% |
Fidelity Select Pharmaceuticals Port |